SCHEMBL13675245

SCHEMBL13675245

C#Cc1cccc(Nc2ncnc3nc(Nc4ccc(S(=O)(=O)N(CCO)CCOC)cc4)sc23)c1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 16/20 0.65
ERBB2 P04626 3/20 0.42
CDK1 P06493 1/20 0.42
PLK4 O00444 1/20 0.42
CIT O14578 1/20 0.42
AURKA O14965 1/20 0.42
GAK O14976 1/20 0.42
EPHB6 O15197 1/20 0.42
SLC22A1 O15245 1/20 0.42
DAPK3 O43293 1/20 0.42
RIPK2 O43353 1/20 0.42
BUB1 O43683 1/20 0.42
KDM1A O60341 1/20 0.42
JAK2 O60674 1/20 0.42
RPS6KA4 O75676 1/20 0.42
STK17B O94768 1/20 0.42
STK10 O94804 1/20 0.42
SLCO2B1 O94956 1/20 0.42
ABCB11 O95342 1/20 0.42
ABL1 P00519 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13672629 0.96 EGFR (0.70) EGFRERBB2CDK1PLK4CIT
SCHEMBL14441621 0.83 EGFR (0.56) EGFRERBB2CDK1PLK4CIT
SCHEMBL13672632 0.81 EGFR (0.61) EGFRERBB2PLK4CITAURKA
SCHEMBL5069412 0.81 EGFR (0.57) EGFRCDK1AURKADYRK1ADYRK1B
SCHEMBL13675038 0.80 EGFR (0.83) EGFRCDK1CYP3A4
SCHEMBL13672630 0.79 EGFR (1.00) EGFRCDK1
SCHEMBL13672634 0.79 EGFR (0.54) EGFRCDK1CDK2HDAC3HDAC1
SCHEMBL14461355 0.78 EGFR (0.80) EGFRCDK1
SCHEMBL13672649 0.75 EGFR (0.67) EGFRDYRK1ADYRK1BHDAC3HDAC1
SCHEMBL13672679 0.73 EGFR (0.58) EGFRERBB2PLK4CITAURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7605154-B2 ATP-protein kinase inhibitors; cytomegalovirus; contraceptive agents; cancer; N7-(3-ethynyl-phenyl)-N2-(4-piperidin-1-ylmethyl-phenyl)-thiazolo[4,5-d]pyrimidine-2,7-diamine JANSSEN PHARMACEUTICA N.V. (BE) 2009-10-20 US disclosed